Clinical trial
Investigation of the Blood Sparing Properties of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty
NCT02569658 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of the Blood Sparing Properties of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty
- Lead sponsor
- Rush University Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2015
- Completion date
- April 30, 2017
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anatomic total shoulder arthroplasty, blood loss, reverse total shoulder arthroplasty, tranexamic acid, transfusion